Suzano raises R$2.5B via CPR-Fs and debentures
Suzano S.A. reports settlement of two new Brazilian real–denominated funding transactions.
Rhea-AI Filing Summary
Suzano S.A. reports settlement of two new Brazilian real–denominated funding transactions. The company completed the 2nd issuance of rural product notes (CPR-Fs) totaling R$2,500,000,000.00, split into a first series maturing in 2036 and a second series maturing in 2038, with fixed interest of 7.0464% and 6.8338% per year, respectively, indexed to IPCA inflation. Suzano also settled the 12th issuance of simple unsecured debentures totaling R$179,000,000.00, maturing in 2041 with fixed interest of 6.1759% per year, also indexed to IPCA. The debentures benefit from tax incentives under Law 12,431, and both issuances used the automatic CVM public offering registration process. The company reiterates its focus on financial discipline and transparency.
Positive
- None.
Negative
- None.
Insights
Suzano secures long-dated, IPCA-linked funding in local markets.
Suzano has raised substantial local-currency funding with the settlement of R$2.5B in CPR-Fs and R$179M in simple debentures. Both instruments are long term, with final maturities between 2036 and 2041, which can help match funding tenor to asset lives.
The CPR-Fs and debentures carry fixed real interest rates of 7.0464%, 6.8338%, and 6.1759% per year, plus IPCA inflation adjustment. This structure ties cash flows to Brazilian inflation, which is common for domestic corporate debt and may reduce real value uncertainty in local terms.
The debentures qualify for the incentive under Law 12,431 because the underlying project is in a priority sector under Decree 11,964. That can broaden the investor base. Overall, this is a notable capital markets transaction but its net effect on leverage and cash flows will depend on how proceeds interact with Suzano’s broader balance-sheet strategy.
Key Figures
Key Terms
CPR-Fs financial
simple debentures financial
IPCA financial
CVM Resolution 160 regulatory
Law 12,431 regulatory
automatic distribution registration rite regulatory
FAQ
What financing transactions does Suzano (SUZ) disclose in this Form 6-K?
What are the main terms of Suzano’s new CPR-F issuances?
What are the key features of Suzano’s new debenture issuance?
How are Suzano’s CPR-Fs and debentures indexed and remunerated?
What regulatory framework applies to Suzano’s new Brazilian issuances?
Does Suzano state the purpose or project for the incentivized debentures?
AI-generated analysis. How Rhea-AI works. Not financial advice.

Vice-President of Finance and Investor Relations